PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials
- DOI
- 10.3389/fonc.2026.1969514
- Published
- 2026-10-21
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1969514,
title = {PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials},
author = {Sumin Lv and Chaoyue Ma and Zeqi Tang and Xinyan Zhang and Wen Shi and Shiyan Zhang and Minyuan Ni and Lihu Gu and Bangsheng Chen},
year = {2026},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2026.1969514},
url = {https://doi.org/10.3389/fonc.2026.1969514}
}RIS
TY - JOUR TI - PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials AU - Sumin Lv AU - Chaoyue Ma AU - Zeqi Tang AU - Xinyan Zhang AU - Wen Shi AU - Shiyan Zhang AU - Minyuan Ni AU - Lihu Gu AU - Bangsheng Chen PY - 2026 JO - Frontiers in Oncology DO - 10.3389/fonc.2026.1969514 UR - https://doi.org/10.3389/fonc.2026.1969514 ER -
APA
Lv, S., Ma, C., Tang, Z., Zhang, X., Shi, W., Zhang, S., Ni, M., Gu, L., & Chen, B. (2026). PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1969514
Source records
- crossref · retrieved 2026-11-07T11:48:03.651Z